Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 3 days ago • JNJ
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
Barrons • 3 days ago • JNJ
This Dividend Pro Likes Banks, Semi-Equipment Stocks, Altria, and J&J
PRNewsWire • 4 days ago • JNJ
Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission
The Motley Fool • 4 days ago • JNJ
Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?
24/7 Wall Street • 4 days ago • JNJ
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.